Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of Jeremy Sokolove, M.D., as Chief Medical Officer. Dr.

On November 2, 2025, Vor Biopharma Inc. amended the employment agreement with its Chief Development Officer, Dr. Qing Zuraw, to include additional severance benefits in case of termination without ...

Vor Biopharma ( (VOR) ) has provided an update. On October 28, 2025, Vor Biopharma Inc. hosted a webcast to present 48-week Phase 3 clinical trial data from China for telitacicept in treating primary ...

Telitacicept delivered consistent quality-of-life improvement across both treatment and placebo crossover arms100% of patients on telitacicept ...

Masih Alinejad, an Iranian-American journalist critical of Iran, was 'chillingly close' to being murdered, the Justice ...

AAVantgarde also received continued strong support from existing investors Longwood Fund and Sofinnova Partners. The proceeds from the financing will support: Completion of clinical PoC of AAVantgarde ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

In what has been described as a scene from a mafia movie, a journalist in Brooklyn, New York, narrowly escaped being ...

From Ellio's to Totino's, these frozen food brands absolutely defined the '90s. Get ready for a walk down memory lane as we ...

Noida: Directorate General of Civil Aviation (DGCA) will oversee calibration flights at Noida International Airport (NIA) on ...

The latest price target for Vor Biopharma (NASDAQ:VOR) was reported by Baird on October 15, 2025. The analyst firm set a price target for $64.00 expecting VOR to rise to within 12 months (a possible ...

A British family`s delightful reaction to Indian ginger tea on the Vande Bharat Express goes viral! See their surprise and ...